Loading clinical trials...
Loading clinical trials...
Neuroplasticity of Pain Pathways and Corneal Afferent Regeneration Following Corneal Crosslinking (CXL) in Keratoconus
Conditions
Locations
1
United States
Boston Children's Hospital
Boston, Massachusetts, United States
Start Date
October 4, 2021
Primary Completion Date
August 1, 2027
Completion Date
December 1, 2027
Last Updated
December 19, 2025
NCT07553000
NCT04577690
NCT07360392
NCT05722002
NCT07512141
NCT06757075
Lead Sponsor
Boston Children's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions